|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,363.00 JPY | +1.55% |
|
+8.59% | +12.90% |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| 08-06 | Japan Earnings Wrap: Kao, Astellas Pharma Rise; Taiyo Yuden Declines | MT |
| Market Cap | 4,237B 26.66B 23.08B 21.57B 19.72B 37.16B 2,543B 37.74B 253B 99.27B 1,272B 100B 97.93B | P/E 2027 * |
11.8x | P/E 2028 * | 12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4,248B 26.73B 23.14B 21.63B 19.77B 37.25B 2,550B 37.84B 254B 99.53B 1,275B 100B 98.19B | EV / Sales 2027 * |
1.86x | EV / Sales 2028 * | 1.82x |
| Free-Float |
98.88% | Yield 2027 * |
3.4% | Yield 2028 * | 3.51% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +1.55% | ||
| 1 week | +8.59% | ||
| Current month | +7.31% | ||
| 1 month | +10.32% | ||
| 3 months | +2.74% | ||
| 6 months | -6.66% | ||
| Current year | +12.90% |
| 1 week | 2,135.5 |  | 2,377 |
| 1 month | 2,109 | | 2,377 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 09/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 31/10/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 09/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 31/05/2019 |
| Director/Board Member | 58 | 31/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.55% | +8.59% | +46.27% | +5.14% | 26.66B | |
| +3.90% | +9.86% | +96.91% | +136.30% | 1,098B | |
| +0.99% | +2.91% | +51.05% | +52.06% | 631B | |
| +0.78% | +1.17% | +25.21% | +63.74% | 438B | |
| +0.01% | +4.33% | +51.52% | +40.75% | 368B | |
| +0.47% | +2.28% | +32.72% | +40.38% | 298B | |
| +0.38% | +2.61% | +9.15% | +9.21% | 251B | |
| +1.52% | +10.12% | +44.75% | +59.20% | 226B | |
| +1.00% | +0.76% | -3.92% | -50.06% | 209B | |
| -0.11% | +1.46% | +11.43% | +66.32% | 165B | |
| Average | +0.56% | +1,717.61% | +36.51% | +42.31% | 371.1B | |
| Weighted average by Cap. | +0.35% | +1,338.18% | +52.03% | +68.38% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,288B 14.4B 12.47B 11.65B 10.65B 20.07B 1,373B 20.38B 137B 53.62B 687B 54.07B 52.89B | 2,101B 13.22B 11.45B 10.7B 9.78B 18.43B 1,261B 18.71B 125B 49.23B 631B 49.64B 48.56B |
| Net income | 343B 2.16B 1.87B 1.75B 1.6B 3.01B 206B 3.06B 20.49B 8.04B 103B 8.11B 7.93B | 324B 2.04B 1.76B 1.65B 1.51B 2.84B 194B 2.89B 19.34B 7.59B 97.26B 7.65B 7.49B |
| Net Debt | 11.12B 70M 60.6M 56.64M 51.76M 97.55M 6.68B 99.07M 664M 261M 3.34B 263M 257M | -418B -2.63B -2.28B -2.13B -1.94B -3.66B -251B -3.72B -24.94B -9.79B -125B -9.87B -9.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | JP¥2,363.00 | +1.55% | 6,287,500 |
| 07/08/26 | JP¥2,327.00 | +1.68% | 8,001,800 |
| 06/08/26 | JP¥2,288.50 | +6.00% | 10,352,900 |
| 05/08/26 | JP¥2,159.00 | -0.44% | 5,388,800 |
| 04/08/26 | JP¥2,168.50 | -0.34% | 6,719,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
